TherapeuticsMD (TXMD) Other Operating Expenses (2010 - 2026)

TherapeuticsMD has reported Other Operating Expenses for 17 years, with the latest figure at $94000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses fell 48.63% year-over-year to $94000.0; the trailing twelve-month figure through Mar 2026 stood at $471000.0 (down 74.22% YoY), and the FY2025 full-year result was $560000.0, down 68.49% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $94000.0, down from $153000.0 in the prior quarter.
• The five-year high for Other Operating Expenses was $143.4 million in Q2 2022, with the low at -$1.4 million in Q1 2022.
• Historically, Other Operating Expenses has averaged $11.0 million across 5 years, with a median of $130500.0 in 2023.
• Annual changes were most pronounced in 2022 — Other Operating Expenses sank 105.83% — and 2024, when it soared 1025.78%.
• TherapeuticsMD's Other Operating Expenses stood at $9.6 million in 2022, then tumbled by 94.4% to $537000.0 in 2023, then tumbled by 80.07% to $107000.0 in 2024, then surged by 42.99% to $153000.0 in 2025, then slumped by 38.56% to $94000.0 in 2026.
• The last three Other Operating Expenses figures came in at $94000.0 (Q1 2026), $153000.0 (Q4 2025), and $128000.0 (Q3 2025), per Business Quant data.